BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25807429)

  • 1. Chronic blockade of class I PI3-kinase attenuates Ang II-induced cardiac hypertrophy and autophagic alteration.
    Yan W; Guo LR; Zhang Q; Sun WZ; O'Rourke ST; Liu KX; Sun CW
    Eur Rev Med Pharmacol Sci; 2015; 19(5):772-83. PubMed ID: 25807429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
    Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway.
    Wu L; Gao L; Zhang D; Yao R; Huang Z; Du B; Wang Z; Xiao L; Li P; Li Y; Liang C; Zhang Y
    Free Radic Biol Med; 2018 Jun; 121():215-230. PubMed ID: 29733904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allicin ameliorates cardiac hypertrophy and fibrosis through enhancing of Nrf2 antioxidant signaling pathways.
    Li XH; Li CY; Xiang ZG; Hu JJ; Lu JM; Tian RB; Jia W
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):457-65. PubMed ID: 22990325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
    Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
    Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea attenuates angiotensin II-induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway.
    Papparella I; Ceolotto G; Montemurro D; Antonello M; Garbisa S; Rossi G; Semplicini A
    J Nutr; 2008 Sep; 138(9):1596-601. PubMed ID: 18716156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-(3-7) alleviates isoprenaline-induced cardiac remodeling via attenuating cAMP-PKA and PI3K/Akt signaling pathways.
    Zhang Y; Shang Z; Liu A
    Amino Acids; 2021 Oct; 53(10):1533-1543. PubMed ID: 34494132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G Protein-Coupled Estrogen Receptor 1 Inhibits Angiotensin II-Induced Cardiomyocyte Hypertrophy via the Regulation of PI3K-Akt-mTOR Signalling and Autophagy.
    Pei H; Wang W; Zhao D; Su H; Su G; Zhao Z
    Int J Biol Sci; 2019; 15(1):81-92. PubMed ID: 30662349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin alleviates isoproterenol-induced cardiac hypertrophy and fibrosis through inhibition of autophagy and activation of mTOR.
    Liu R; Zhang HB; Yang J; Wang JR; Liu JX; Li CL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7500-7508. PubMed ID: 30468499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase.
    Gorin Y; Kim NH; Feliers D; Bhandari B; Choudhury GG; Abboud HE
    FASEB J; 2001 Sep; 15(11):1909-20. PubMed ID: 11532971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rap1GAP Mediates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Inhibiting Autophagy and Increasing Oxidative Stress.
    Gao Y; Zhao D; Xie WZ; Meng T; Xu C; Liu Y; Zhang P; Bi X; Zhao Z
    Oxid Med Cell Longev; 2021; 2021():7848027. PubMed ID: 33936386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of PI3-Kinase in Angiotensin II-Induced Cardiac Hypertrophy: Class I Versus Class III.
    Zhong T; Wang Z; Niloy SI; Shen Y; O'Rourke ST; Sun C
    Front Pharmacol; 2021; 12():608523. PubMed ID: 33664668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K/Akt pathway.
    Lin L; Liu X; Xu J; Weng L; Ren J; Ge J; Zou Y
    J Cell Mol Med; 2015 Aug; 19(8):1929-38. PubMed ID: 25946687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy.
    Zhou L; Ma B; Han X
    J Mol Endocrinol; 2016 Nov; 57(4):R143-R152. PubMed ID: 27620875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alarin moderated myocardial hypertrophy via inhibiting cyclic adenosine monophosphate/protein kinase A signaling pathway to attenuate autophagy.
    Shen T; Liu Y; Dong S; Xu X; Wang X; Li Y; Zhou L
    Peptides; 2021 Dec; 146():170669. PubMed ID: 34624429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
    Li AL; Lv JB; Gao L
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5462-5470. PubMed ID: 29243791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
    Yang J; Zhu HH; Chen GP; Ye Y; Zhao CZ; Mou Y; Hu SJ
    Int J Biochem Cell Biol; 2013 Mar; 45(3):657-66. PubMed ID: 23277274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
    Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.